The CUTX-101 NDA was initially granted Priority Review by the FDA and is supported by positive topline clinical efficacy results for CUTX-101, demonstrating significant improvement in overall survival ...
Modern Engineering Marvels on MSN
Nothing’s Playground Lets Users Build Mini Apps From Prompts
Might the future of smartphone innovation not be in hardware features, but in AI that creates apps as needed? London smartphone manufacturer Nothing is wagering on it. The firm has launched Playground ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback